PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19
Lists
Only you see this
Abstract
Pharmacogenomics (PGx) is a key area of precision medicine, which is already being implemented in some health systems and may help guide clinicians toward effective therapies for individual patients. Over the last 2 decades, the Pharmacogenomics Knowledgebase (PharmGKB) has built a unique repository of PGx knowledge, including annotations of clinical guideline and regulator-approved drug labels in addition to evidence-based drug pathways and annotations of the scientific literature. All of this knowledge is freely accessible on the PharmGKB website. In the first of a series of PharmGKB tutorials, we introduce the PharmGKB coronavirus disease 2019 (COVID-19) portal and, using examples of drugs found in the portal, demonstrate some of the main features of PharmGKB. This paper is intended as a resource to help users become quickly acquainted with the wealth of information stored in PharmGKB.
BibTeX
@inproceedings{huddart2020pharmgkb,
author = {Rachel Huddart and Michelle Whirl‐Carrillo and Russ B. Altman and Teri E. Klein},
title = {{PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19}},
booktitle = {Clinical},
year = {2020},
doi = {10.1002/cpt.2067},
}Loading related content...